NATIONAL BONE MARROW TRANSPLANT LINK (EIN 383027625) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1992

Legal Domicile

Principal Officer

MARGARET BURKHARD

Phone

2483581886

Tax Period

2024-02-01 to 2025-01-31

NATIONAL BONE MARROW TRANSPLANT LINK, founded in 1992, is a small nonprofit in the Medical Research sector that reported $290K in total revenue in fiscal year 2024.

Mission

THE MISSION OF THE NATIONAL BONE MARROW TRANSPLANT LINK IS TO HELP PATIENTS, CAREGIVERS, AND FAMILIES COPE WITH THE SOCIAL AND EMOTIONAL CHALLENGES OF BONE MARROW/STEM CELL TRANSPLANT FROM DIAGNOSIS THROUGH SURVIVORSHIP BY PROVIDING VITAL INFORMATION AND PERSONALIZED SUPPORT SERVICES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $282,018

Program Service Revenue $1,989

Investment Income $3,659

Other Revenue $2,525

TOTAL REVENUE $290,191

Expense Breakdown

Grants Paid $0

Salaries & Benefits $145,255

Fundraising Expenses $33,354

Program Expenses $210,634

Other Expenses $163,016

TOTAL EXPENSES $308,271

Year-over-Year Comparison

	2024	2023	Change
Revenue	$290,191	$294,698	0.0%
Expenses	$308,271	$314,869	0.0%
Net Income	$-18,080	$-20,171	-0.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$84,103

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MIKE SERRA	PRESIDENT	1.00	Officer Director	$0	$0	$0
BRIDGET N CASEY MDIV PHD	TREASURER	1.00	Officer Director	$0	$0	$0
LEW CHRISTIE	BOARD MEMBER	1.00	Director	$0	$0	$0
BETH ADES	BOARD MEMBER	1.00	Director	$0	$0	$0
SHARDE FLUTZ	BOARD MEMBER	1.00	Director	$0	$0	$0
FLORA WEI STONDELL FNP	BOARD MEMBER	1.00	Director	$0	$0	$0
MARGARET BURKHARD	EXECUTIVE DIRECTOR	40.00	Officer	$84,103	$0	$84,103

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$290,191	$308,271	$231,719	$-18,080
2024	$294,698	$314,869	$250,520	$-20,171
2023	$322,723	$282,089	$255,616	$40,634
2022	$260,266	$264,669	$214,982	$-4,403
2021	$253,414	$228,944	$219,385	$24,470
2020	$216,036	$243,794	$194,915	$-27,758
2019	$298,405	$248,584	$222,673	$49,821

NATIONAL BONE MARROW TRANSPLANT LINK